08.04.24 | Vollzeit | Augsburg, Königsbrunn, Untersc | CatalYm GmbHAnd produce clinically significant outcomes in patients previously unresponsive to immunotherapy. Building upon highly promising results from Phase 2 clinical trials, Visugromab is now poised to advance through mid-stage to late-stage clinical development. As we remain steadfast in our commitment to bringing
Später ansehen08.04.24 | Vollzeit | Augsburg, Königsbrunn, Untersc | CatalYm GmbHAnd produce clinically significant outcomes in patients previously unresponsive to immunotherapy. Building upon highly promising results from Phase 2 clinical trials, Visugromab is now poised to advance through mid-stage to late-stage clinical development. As we remain steadfast in our commitment to bringing
Später ansehen08.04.24 | Vollzeit | Augsburg, Königsbrunn, Untersc | CatalYm GmbHAnd produce clinically significant outcomes in patients previously unresponsive to immunotherapy. Building upon highly promising results from Phase 2 clinical trials, Visugromab is now poised to advance through mid-stage to late-stage clinical development. As we remain steadfast in our commitment to bringing
Später ansehen08.04.24 | Vollzeit | Augsburg, Königsbrunn, Untersc | CatalYm GmbHAnd produce clinically significant outcomes in patients previously unresponsive to immunotherapy. Building upon highly promising results from Phase 2 clinical trials, Visugromab is now poised to advance through mid-stage to late-stage clinical development. As we remain steadfast in our commitment to bringing
Später ansehen08.04.24 | Vollzeit | Augsburg, Königsbrunn, Untersc | CatalYm GmbHAnd produce clinically significant outcomes in patients previously unresponsive to immunotherapy. Building upon highly promising results from Phase 2 clinical trials, Visugromab is now poised to advance through mid-stage to late-stage clinical development. As we remain steadfast in our commitment to bringing
Später ansehen08.04.24 | Vollzeit | Augsburg, Königsbrunn, Untersc | CatalYm GmbHAnd produce clinically significant outcomes in patients previously unresponsive to immunotherapy. Building upon highly promising results from Phase 2 clinical trials, Visugromab is now poised to advance through mid-stage to late-stage clinical development. As we remain steadfast in our commitment to bringing
Später ansehen08.04.24 | Vollzeit | Augsburg, Königsbrunn, Untersc | CatalYm GmbHAnd produce clinically significant outcomes in patients previously unresponsive to immunotherapy. Building upon highly promising results from Phase 2 clinical trials, Visugromab is now poised to advance through mid-stage to late-stage clinical development. As we remain steadfast in our commitment to bringing
Später ansehen
01.04.24 | Vollzeit | München | JobLeads GmbH | 100.000 € - 125.000 € By the hiring manager when considering the candidate’s eligibility. • Specific experience required of at least 7 year’s duration within one of the following categories Oncology Clinical Trial management or Large safety registries and Real world experience trials. • Requires strong clinical research operational
Später ansehen01.04.24 | Vollzeit | München | JobLeads GmbH | 100.000 € - 125.000 € Senior Regional Site Manager (Senior RSM) is responsible for overseeing the conduct of clinical trials at investigative sites to ensure the quality and integrity of data and to ensure that the rights and welfare of research subjects are protected. The Senior RSM conducts all monitoring visits
Später ansehenVerpassen Sie nie wieder einen passenden Job!
Alle Jobs für Clinical Trial Management in Deutschland kostenlos abonnieren.